Your browser doesn't support javascript.
loading
Acute Liver Rejection in a Multiple Myeloma Patient Treated with Lenalidomide.
Vaxman, Iuliana; Eaton, John; Lee, Hee Eun; Gertz, Morie A.
Afiliación
  • Vaxman I; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Eaton J; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center Petah-Tikva, Israel.
  • Lee HE; Sackler Faculty of Medicine Tel-Aviv University, Tel-Aviv, Israel.
  • Gertz MA; Division of gastroenterology and hepatology, Mayo Clinic, Rochester, MN, USA.
Case Rep Transplant ; 2020: 8894922, 2020.
Article en En | MEDLINE | ID: mdl-33381347
ABSTRACT
Herein we present a patient that underwent a liver transplant due to primary biliary cholangitis (PBC) and after 9 years developed multiple myeloma. Following the cessation of mycophenolate mofetil and 2 weeks after lenalidomide treatment was started, the patient experienced acute cellular rejection. The patient recovered after treatment with corticosteroids, resumption of mycophenolate mofetil, and cessation of lenalidomide. Lenalidomide-associated allograft rejection has been reported in other organs. However, this is the first case report of liver rejection induced by lenalidomide.

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Case Rep Transplant Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Case Rep Transplant Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos